Emirates Pharmaceuticals recommends adopting artificial intelligence to improve manufacturing and distribution processes

The Board of Directors of the Emirates Drug Corporation stressed the importance of adopting advanced technologies such as artificial intelligence and digital technologies to improve manufacturing and distribution processes, which contributes to accelerating the pace of innovation and providing sustainable health solutions by providing medical products and innovative treatments that meet the needs of society, enhance drug and health security in the country, and consolidate the position of The UAE is a leader in global health innovation.

During its last meeting for the year 2024, chaired by His Excellency Dr. Thani bin Ahmed Al Zeyoudi, Minister of State for Foreign Trade and Chairman of the Board of Directors of the Emirates Drug Corporation, the Foundation’s Board of Directors discussed plans to develop innovative medical products and modernize regulatory frameworks to enhance drug security in the UAE, in addition to mechanisms for enhancing international cooperation and attracting Investments in research and development, to achieve the UAE’s vision of becoming a global center for medical and pharmaceutical innovation.

His Excellency Dr. Thani Al Zeyoudi stressed that the Emirates Pharmaceutical Corporation plays an essential role in achieving the state’s vision to enhance innovation and sustainability in the medical and pharmaceutical industries sector, noting that the pharmaceutical and medical industries represent a vital sector for achieving the sustainability of the health system and enhancing its readiness to face future challenges..

He said that the Emirates Pharmaceutical Corporation continues to work on developing innovative solutions and strategic partnerships that contribute to strengthening the country’s position as a global center for pharmaceutical innovation and achieving national goals in this vital sector, noting that investing in modern technologies enhances the corporation’s ability to face future challenges and find advanced solutions that contribute to Improving the health care system and its sustainability.

During the meeting, which was attended by His Excellency Dr. Maha Tayseer Barakat, Vice President of the Council, Dr. Fatima Muhammad Hilal Al Kaabi, Director General of the Foundation, Dr. Issa Abdel Fattah Kazim, Badr Salim Al Olama, Dr. Amer Ahmed Sharif, Dr. Farhan Malak, and Professor Chris Evans, members of the Board of Directors, The Council reviewed the most prominent achievements achieved during the current year, and developments in implementing the organization’s strategy for the years 2024-2026, in addition to identifying strategic priorities. And the work plan for the next stage, within the framework of the Foundation’s commitment to enhancing innovation and sustainability in the medical and pharmaceutical industries, and supporting its operational and research capabilities..

Dr. Fatima Mohammed Hilal Al Kaabi said that the Foundation continues to implement its strategic plans to achieve its ambitious vision and has made remarkable progress in developing the organizational structure and strengthening research partnerships, which contributes to improving the quality of life of society and supporting sustainable economic growth. .

The Council reviewed the efforts made to develop regulatory frameworks and national strategies aimed at enhancing pharmaceutical research and scientific studies. The importance of applying global standards for quality and safety in the pharmaceutical industries was also highlighted, in addition to setting priorities for international cooperation to accelerate the pace of innovation and development of advanced treatments..